Strategy for the treatment of noncompliant hypertensive hemodialysis patients

International Journal of Artificial Organs

Volumn 25, Issue 11, 2002, Pages 1061-1065

  Ross, Edward A ^a   Pittman, T B ^a   Koo, L C ^a  

^a UNIVERSITY OF FLORIDA   (United States)

Author keywords

Hemodialysis; Hypertension; Noncompliance

Indexed keywords

BLOOD PRESSURE; HEMODIALYZERS; PATIENT TREATMENT;

AMLODIPINE; HAEMODIALYSIS; HEMODIALYSIS PATIENT; HIGH BLOOD PRESSURES; HYPERTENSION; LISINOPRIL; MEAN PRESSURES; NONCOMPLIANCE; SIGN-OFF; SUBSTANCE ABUSE;

DIALYSIS;

AMLODIPINE; ANTIHYPERTENSIVE AGENT; CLONIDINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERYTHROPOIETIN; LISINOPRIL; LONG ACTING DRUG;

ADULT; ARTICLE; BLOOD PRESSURE REGULATION; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL PROTOCOL; DATA ANALYSIS; DIASTOLIC BLOOD PRESSURE; DISEASE SEVERITY; DRINKING; DRUG DOSE REGIMEN; DRUG HALF LIFE; DRUG SELF ADMINISTRATION; FEMALE; FOLLOW UP; HEMODIALYSIS PATIENT; HIGH RISK PATIENT; HUMAN; HYPERTENSION; INFORMATION PROCESSING; KIDNEY FAILURE; MALE; MAXIMUM PERMISSIBLE DOSE; MEDICAL STAFF; MONOTHERAPY; PATIENT ATTITUDE; PATIENT COMPLIANCE; RETROSPECTIVE STUDY; SIDE EFFECT; SOCIOECONOMICS; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE; SUBSTANCE ABUSE; SYSTOLIC BLOOD PRESSURE; TREATMENT PLANNING;

EID: 0036868249     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880202501104     Document Type: Article

References (19)

1. Ma KW, Greene EL, Raij L. Cardiovascular risk factors in chronic renal failure and hemodialysis populations. Am J Kidney Dis 1992; 19: 505-13.
2. Ritz E, Koch M. Morbidity and mortality due to hypertension in patients with renal failure. Am J Kidney Dis 1993; 21 (suppl 2): S113-8.
3. Degoulet P, Legrain M, Reach I, Aime F, Devries C, Rojas P, Jacobs C. Mortality risk factors in patients treated by chronic hemodialysis: Report of the diaphane collaborative study. Nephron 1982; 31: 103-10.
4. Van Schaik BAM, Geyskes GG, Van Der Wouw PA, Van Rooij HH, Porsius AJ. Pharmacokinetics of lisinopril in hypertensive patients with normal and impaired renal function. Eur J Clin Pharmacol 1988; 34: 61-5.
5. Hoyer J, Schulte KL, Lenz T. Clinical pharmacokinetics of angiotensin converting enzyme (ACE) inhibitors in renal failure. Clin Pharmacokinet 1993; 24: 230-54.
6. Kelly JG, Doyle GD, Carmody M, Glover DR, Cooper WD. Pharmacokinetics of lisinopril, enalapril and enalaprilat in renal failure: Effects of haemodialysis. Br J Clin Pharmacol 1988; 26: 781-6.
7. Lowenthal DT, Saris SD, Paran E, Cristal N. The use of transdermal clonidine in the hypertensive patient with chronic renal failure. Clin Nephrol 1993; 39: 37-43.
8. Rosansky SJ, Johnson KL, McConnell J. Use of transdermal clonidine in chronic hemodialysis patients. Clin Nephrol 1993; 39: 32-6.
9. Meredith PA, Elliott H.L. Clinical pharmacokinetics of amlodipine. Clin Pharmacokinet 1992; 22: 22-31.
10. Doyle GD, Donohue J, Carmody M, Laher M, Greb H, Volz M. Pharmacokinetics of amlodipine in renal impairment. Eur J Clin Pharmacol 1989; 36: 205-8.
11. Collins AJ, Ma JZ, Umen A, Keshaviah P. Urea index and other predictors of hemodialysis patient survival. Am J Kidney Dis 1994; 23: 272-82.
12. Hoover H. Compliance in hemodialysis patients: A review of the literature. J Am Diet Assoc 1989; 89 957-9.
13. Rocco MV, Burkart JM. Prevalence of missed treatments and early sign-offs in hemodialysis patients. J Am Soc Nephrol 1993; 4: 1178-83.
14. Bame SI, Petersen N, Wray NP. Variation in hemodialysis patient compliance according to demographic characteristics. Soc Sci Med 1993; 37: 1035-43.
15. Charra B, Calemard E, Ruffet M, Chazot C, Terrat J-C, Vanel T, Laurent G. Survival as an index of adequacy of dialysis. Kidney Int 1992; 41: 1286-91.
16. Francis CK. Hypertension, cardiac disease, and compliance in minority patients. Am J Med 1991; 91 (suppl 1A): S29-36.
17. Burris JF, Papademetriou V, Wallin JD, Cook ME, Weidler DJ. Therapeutic adherence in the elderly: Transdermal clonidine compared to oral verapamil for hypertension. Am J Med 1991; 91 (suppl 1A): S22-8.
18. Weidler D, Wallin JD, Cook E, Dillard D, Lewin A. Transdermal clonidine as an adjunct to enalapril: An evaluation of efficacy and patient compliance. J Clin Pharmacol 1992; 32: 444-9.
19. Branche GC Jr, Batts JM, Dowdy VM, Fields LS, Francis CK. Improving compliance in an inner-city hypertensive patient population. Am J Med 1991; 91 (suppl 1A): S37-41.